Is GlucoTrack Inc (GCTK) overvalued? · P/E 0.1, $4.1M cap
GlucoTrack Inc (GCTK) is a medical instruments & supplies company listed on US.
This page asks whether GlucoTrack Inc (GCTK) looks expensive on cached numbers — not a short thesis.
No cached income statement for GCTK, so there is no earnings base to call rich or cheap.
GCTK currently screens at market cap $4.1M and trailing P/E 0.1. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next GCTK 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the GCTK stock page for the full model, not this heading.
Not investment advice.